Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00230126
What this trial is testing

OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ohio State University Comprehensive Cancer Center 57
Large-scale testing (Phase 3)Active Not RecruitingNCT04208178
What this trial is testing

Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation

Who this might be right for
Advanced HER2+Breast Cancer
Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)WithdrawnNCT02011126
What this trial is testing

Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Liver Cancer+5 more
Children's Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT02479178
What this trial is testing

BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Urothelial CarcinomaCholangiocarcinomaCervical Cancer+1 more
BIND Therapeutics 73
Early research (Phase 1)Study completedNCT00074243
What this trial is testing

CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00061815
What this trial is testing

Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 102
Testing effectiveness (Phase 2)Study completedNCT01222936
What this trial is testing

LBH Phase II in Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Carcinoma
Southern Europe New Drug Organization 21
Not applicableNo Longer AvailableNCT05269771
What this trial is testing

MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals
Not applicableActive Not RecruitingNCT07485634
What this trial is testing

Risk-Based Geriatric Assessment-Driven Management in Older Patients Starting Chemotherapy

Who this might be right for
CancerGeriatric SyndromeFrailty+1 more
The University of Hong Kong 70
Testing effectiveness (Phase 2)Study completedNCT01523834
What this trial is testing

Oral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCT

Who this might be right for
Diffuse Large B-cell Lymphoma
Fondazione Italiana Linfomi - ETS 35
Testing effectiveness (Phase 2)WithdrawnNCT04044209
What this trial is testing

The IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDS

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Yale University
Not applicableLooking for participantsNCT06983899
What this trial is testing

Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial

Who this might be right for
Lung Non-Small Cell Carcinoma
Fred Hutchinson Cancer Center 100
Testing effectiveness (Phase 2)UnknownNCT04223999
What this trial is testing

Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)

Who this might be right for
Recurrent Glioblastoma
Anders Rosendal Korshøj 70
Large-scale testing (Phase 3)Ended earlyNCT04745832
What this trial is testing

Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)

Who this might be right for
Follicular Lymphoma (FL)Non Hodgkin LymphomaMarginal Zone Lymphoma
MEI Pharma, Inc. 82
Not applicableEnded earlyNCT00727532
What this trial is testing

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Hereditary Clear Cell Renal Cell CarcinomaKidney Cancer
Northwestern University 9
Large-scale testing (Phase 3)Study completedNCT02153398
What this trial is testing

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

Who this might be right for
Gastric Ulcer (GU)Duodenal Ulcer (DU)Anastomotic Ulcer (AU)+3 more
AstraZeneca 55
Early research (Phase 1)Study completedNCT00027898
What this trial is testing

Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 27
Not applicableActive Not RecruitingNCT01653093
What this trial is testing

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
University of Cincinnati 280
Testing effectiveness (Phase 2)Ended earlyNCT00004221
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer

Who this might be right for
Malignant Ovarian Mixed Epithelial TumorOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid Adenocarcinoma+5 more
Gynecologic Oncology Group 12
Not applicableLooking for participantsNCT05160584
What this trial is testing

Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Janssen Pharmaceutica N.V., Belgium 300
Next Page